42
Participants
Start Date
April 16, 2018
Primary Completion Date
June 6, 2023
Study Completion Date
December 20, 2023
GLP-1 agonists
Liraglutide: 6 mg/ml Semaglutide: 1.34 mg/ml Dulaglutide: de 0.75 mg ou 1.5 mg
Cardiac MRI
T3 myocardial MRI (total acquisition time : 1h) performed before initiation of treatment and measuring the concentration of intramyocardial triglycerides (\[TG\] by NMR spectroscopy, parameters of cardiac morphology (myocardial mass, (epicardial fat surface, pericardial fat surface), function (LVEF, SV, TDV, PFR, TPFR) and tissue parameters (extracellular volume, left myocardial fibrosis volume).
Follow up by phone
at 2 and 4 mois
Chu Dijon Bourgogne, Dijon
Centre Hospitalier Universitaire Dijon
OTHER